Alligo Valuation
Is 0RTK undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0RTK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 0RTK (SEK142.8) is trading below our estimate of fair value (SEK461.26)
Significantly Below Fair Value: 0RTK is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0RTK?
Other financial metrics that can be useful for relative valuation.
What is 0RTK's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | SEK 7.09b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.1x |
Enterprise Value/EBITDA | 11.4x |
PEG Ratio | 0.7x |
Price to Earnings Ratio vs Peers
How does 0RTK's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 14.2x | ||
AT. Ashtead Technology Holdings | 19.3x | 14.1% | UK£473.8m |
LTHM James Latham | 12.1x | -3.4% | UK£274.5m |
ASY Andrews Sykes Group | 13.1x | n/a | UK£226.0m |
MACF Macfarlane Group | 12.1x | 9.2% | UK£178.3m |
0RTK Alligo | 17.3x | 23.7% | SEK 7.1b |
Price-To-Earnings vs Peers: 0RTK is expensive based on its Price-To-Earnings Ratio (17.3x) compared to the peer average (14.2x).
Price to Earnings Ratio vs Industry
How does 0RTK's PE Ratio compare vs other companies in the European Trade Distributors Industry?
Price-To-Earnings vs Industry: 0RTK is expensive based on its Price-To-Earnings Ratio (17.3x) compared to the European Trade Distributors industry average (16.2x).
Price to Earnings Ratio vs Fair Ratio
What is 0RTK's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 17.3x |
Fair PE Ratio | 24.9x |
Price-To-Earnings vs Fair Ratio: 0RTK is good value based on its Price-To-Earnings Ratio (17.3x) compared to the estimated Fair Price-To-Earnings Ratio (24.9x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | SEK 142.80 | SEK 177.50 +24.3% | 1.4% | SEK 180.00 | SEK 175.00 | n/a | 2 |
Sep ’25 | SEK 138.60 | SEK 177.50 +28.1% | 1.4% | SEK 180.00 | SEK 175.00 | n/a | 2 |
Aug ’25 | SEK 141.60 | SEK 177.50 +25.4% | 1.4% | SEK 180.00 | SEK 175.00 | n/a | 2 |
Jul ’25 | SEK 146.40 | SEK 177.50 +21.2% | 1.4% | SEK 180.00 | SEK 175.00 | n/a | 2 |
Jun ’25 | SEK 139.00 | SEK 177.50 +27.7% | 1.4% | SEK 180.00 | SEK 175.00 | n/a | 2 |
May ’25 | SEK 129.60 | SEK 177.50 +37.0% | 1.4% | SEK 180.00 | SEK 175.00 | n/a | 2 |
Apr ’25 | SEK 154.00 | SEK 177.50 +15.3% | 1.4% | SEK 180.00 | SEK 175.00 | n/a | 2 |
Feb ’25 | SEK 132.80 | SEK 137.50 +3.5% | 1.8% | SEK 140.00 | SEK 135.00 | n/a | 2 |
Jan ’25 | SEK 124.01 | SEK 137.50 +10.9% | 1.8% | SEK 140.00 | SEK 135.00 | n/a | 2 |
Dec ’24 | SEK 102.60 | SEK 137.50 +34.0% | 1.8% | SEK 140.00 | SEK 135.00 | n/a | 2 |
Nov ’24 | SEK 89.18 | SEK 137.50 +54.2% | 1.8% | SEK 140.00 | SEK 135.00 | n/a | 2 |
Feb ’24 | n/a | SEK 129.50 0% | 8.1% | SEK 140.00 | SEK 119.00 | SEK 132.80 | 2 |
Jan ’24 | SEK 78.30 | SEK 125.00 +59.6% | 12.0% | SEK 140.00 | SEK 110.00 | SEK 124.01 | 2 |
Dec ’23 | SEK 80.40 | SEK 125.00 +55.5% | 12.0% | SEK 140.00 | SEK 110.00 | SEK 102.60 | 2 |
Nov ’23 | SEK 89.50 | SEK 125.00 +39.7% | 12.0% | SEK 140.00 | SEK 110.00 | SEK 89.18 | 2 |
Oct ’23 | SEK 78.31 | SEK 147.50 +88.4% | 11.9% | SEK 165.00 | SEK 130.00 | SEK 102.20 | 2 |
Sep ’23 | SEK 94.00 | SEK 147.50 +56.9% | 11.9% | SEK 165.00 | SEK 130.00 | SEK 103.27 | 2 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.